Pharmaceutical tablet
Latest Merck & Co., Inc. Patents:
- Assays for resistance to echinocandin-class drugs
- ASSAYS FOR RESISTANCE TO ECHINOCANDIN-CLASS DRUGS
- Assays for resistance to echinocandin-class drugs
- INTEGRIN TARGETING AGENTS AND IN-VIVO AND IN-VITRO IMAGING METHODS USING THE SAME
- Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
Description
FIG. 1 is a top plan view of a pharmaceutical tablet showing our new design;
FIG. 2 is a bottom plan view thereof;
FIG. 3 is a bottom plan view of a second embodiment of the pharmaceutical tablet;
FIG. 4 is a fragmentary side elevational view thereof; and,
FIG. 5 is a cross sectional view taken along line 5--5 of FIG. 1.
The undisclosed top and sides views of the second embodiment being the same as the first embodiment.
Referenced Cited
Patent History
Patent number: D379223
Type: Grant
Filed: Sep 13, 1995
Date of Patent: May 13, 1997
Assignee: Merck & Co., Inc. (Rahway, NJ)
Inventors: Kenneth A. Kramer (Green Lane, PA), Ashok V. Katdare (Norristown, PA)
Primary Examiner: Kay H. Chin
Attorneys: Robert J. North, Melvin Winokur
Application Number: 0/43,867
Type: Grant
Filed: Sep 13, 1995
Date of Patent: May 13, 1997
Assignee: Merck & Co., Inc. (Rahway, NJ)
Inventors: Kenneth A. Kramer (Green Lane, PA), Ashok V. Katdare (Norristown, PA)
Primary Examiner: Kay H. Chin
Attorneys: Robert J. North, Melvin Winokur
Application Number: 0/43,867
Classifications
Current U.S. Class:
Tablet Or Caplet (1) (D24/101);
Pharmaceutical Product (D24/100)
International Classification: 2801;
International Classification: 2801;